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1. Introduction 
The human body adapts to the space environment in a number of direct and indirect ways.  
With the near-removal of gravitational forces, body fluid tends to move headwards from the 
lower extremities. As the body adapts to this changed distribution of fluid, plasma volume 
in the blood decreases within days. This change increases the relative concentration of red 
blood cells in the blood, which may be a factor in the observed decrease in red blood cell 
generation. (For discussion of this and similar issues, see, e.g., (Blaber et al., 2010)). Newly 
modified concentrations of various dissolved gases, hormones, electrolytes, and other 
substances induce a cascade of inter-woven effects. Other direct effects of space include 
conformational changes in compliant tissue, including the shape of the heart. Muscles tend 
to atrophy without the challenge of gravitational loading. More troubling, key regions in the 
load-bearing skeleton, such as the hip and lumbar spine, can lose mass at a rate of 1.5-2.5% 
per month, at least for several months. Aside from the loss of gravitational loading, other 
environmental factors include radiation exposure (Akopova et al., 2005), altered light/dark 
cycles, and the psychological stress of living in a confined space in a dangerous environment 
with only a few people for months at a time. Biomedical research continues to expand our 
knowledge base and provide insights into the short- and long-term effects of spaceflight on 
the human body. Space medicine is concerned with the more immediate needs of astronaut 
patients who are living in low earth orbit right now. Both of these tasks require 
biodiagnostic tools that give meaningful information.  
The retirement of the Space Shuttle removes the primary avenue for returning astronaut 
blood samples to earth for lab analysis. This requires a shift in focus from ground-based 
analysis of space-exposed samples to on-orbit analysis. While this is a significant challenge, 
it also provides an opportunity to use the International Space Station (ISS) to develop next-
generation medical diagnostics for space. For long-duration spaceflight, we know that the 
crew will have to operate at an unprecedented level of autonomy. The need for compact, 
efficient, reliable, adaptable diagnostics will be critical for maintaining the health of the crew 
and their environment. The ISS can be used as a proving ground for these emerging 
technologies so that we can refine these tools before the need becomes urgent.   
The demands placed on onboard diagnostics are not simple to meet. Minimal resources for 
power, storage, excess volume and mass are available. Assume that the entire medical supply 
kit for long-duration spaceflight will be roughly the size of a shoebox. Little or no supply chain 
is to be expected. Devices and their supporting reagents and additives must remain viable for 
www.intechopen.com
  
Biomedical Engineering – From Theory to Applications 
 
132 
several years. They must operate safely and reliably in an extreme envi-ronment. We would 
like to have testing capabilities that could respond to current needs as well as to evolving 
priorities. For blood analysis, we would like to perform routine chemis-try panels and cell 
counts as well as examine an array of biomarkers (some as yet unknown), which would aid in 
detecting radiative damage and assessing changes in bone, immune, cardiovascular, 
neurological, renal, and other functions.  Aside from blood analysis, urine or saliva could 
provide useful diagnostic data while reducing invasiveness to the astronaut. Consequently, we 
would like to design towards a device that could accept other sample types including cell 
cultures, animal blood and urine, and environmental samples like potable water.   
On earth, the Holy Grail for portable medical diagnostics is the development of a self-
contained, robust, general-purpose assay system for analysis of bodily or environmental 
fluids.  While this remains the goal, most research today focuses on bits and pieces of such a 
device, such as separation processes, onboard miniaturized sensors, or the development of 
highly specialized assays, e.g., detection of specific cancers. There are fewer investigations 
that focus on integration of sample introduction, processing, and detection with wide-
ranging capability. But the pace of such development has progressed rapidly over the last 
decade. Most systems rely heavily on disposable components, which are a luxury for a 
spacebound tool. Devices that depend on bulky external infrastructure for optics, flow 
control or application of magnetic, electric, or optical fields are also ill-suited for space.  
Dynamic reconfiguration of device capabilities to accommodate different assays or sample 
types can be achieved with flow control and/or biochip-based reconfiguration, but these 
modular concepts remain more of an interesting oddity at present than a regularly 
employed strategy in biochip development. Complete integration, miniaturization, 
adaptability and breadth of capability are all essential features of a spaceworthy device.   
On the commercial side, there are a handful of point-of-care devices that provide general-
ized blood analysis. None of these devices span the breadth of assays specified by the most 
current medical requirements (International Space Station Program, 2004). For a discussion, 
see (Nelson & Chait, 2010).  For these devices, the design paradigm is a suite of disposable 
cartridges, coupled with a reusable reader. But for space travelers on extended missions, the 
volume and mass of the disposable components for these commercial systems are 
prohibitively large.  Moreover, the shelf life is grossly inadequate. 
For the past decade, NASA has invested in the development of next-generation medical 
diagnostics. In this chapter, we consider the benefit of squeezing down the resource 
requirements by limiting the use of disposable components. Instead, we emphasize the 
reuse of the microfluidic and detection infrastructure if cross-contamination can be avoided. 
The basic technology exists today to build a reusable microscale lab analysis tool that is 
versatile, resource-conscious, and miniaturized to an extent that beats the commercial 
devices by a very large margin. The primary obstacles are in development, specifically, the 
integration of all the functional components into a single device, the capacity for massive 
multiplexing and the broad availability of appropriate assays. Many excellent reviews on 
microfluidics are available in the literature, including (Arora et al., 2010; Bhagat et al., 2010; 
Chan, 2009; Chang & Yang, 2007; Cho et al., 2010; De Volder & Reynaerts, 2010; Di Carlo, 
2009; Gossett et al., 2010; Huh et al., 2009; Hwang & Park, 2011; Kim & Ligler, 2010; Kist & 
Mandaji, 2004; Kuswandi et al., 2007; Lange et al., 2008; Lenshof & Laurell, 2010; Mogensen 
& Kutter, 2009; Mukhopadhyay, 2005; Pamme, 2006; Pamme, 2007; Salieb-Beugelaar et al., 
2010; Sun & Morgan, 2010).  Consequently, in this work, we will focus on the new directions 
that will reduce resource consumption, improve adaptability and expand breadth while 
increasing diagnostic value within the framework of a single device. 
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2. Requirements for spacebound devices 
Diagnostics in space must be stingy with resources, such as volume, mass, power and rea-
gent consumption. Ideally, biomedical devices should be highly adaptable to meet evolving 
needs of space medicine, biomedical research, plant, cell and animal biology, and 
environmental monitoring. Devices and their supporting reagents and additives must 
sustain performance during a multi-year lifetime in a low-gravity environment, 
characterized by radiation, low humidity and the lack of refrigeration. Efforts to reduce 
additives, expand capability, amplify ruggedness and simplify controls will ultimately be 
beneficial for all next-generation medical devices, whether for use on earth or in space.   
2.1 Resource consumption 
In 2010, a prototype microfluidic device purified water and mixed it with salt crystals on 
orbit to deliver medical-grade saline solution in an approach described by (Niederhaus et 
al., 2008). This technique could maintain the availability of saline for medical or lab use on 
the Space Station, while eliminating the need to consume limited storage space in resupply 
vehicles. But in general, additives, including reagents, buffers, and clean water, are very 
limited. No dedicated hardware can be expected for cleaning or storage. Every pipette, 
lancet, cleansing wipe, and other supplies used for device operation or maintenance must be 
considered as part of an assay system’s resource “load” and scrutinized for potential 
savings. From the standpoint of resource efficiency, the microdevices fabricated by 
embedding polymer microchannels on paper by Whitesides and co-workers are noteworthy 
(Martinez et al., 2010).  A droplet of blood is applied to a snippet of paper, which uses 
capillary action to draw the sample through the device to colorimetric sensor pads. The 
overall system is extremely small, requires no power or other infrastructure for qualitative 
measurement, and can easily perform several blood tests simultaneously. Expanding its 
capabilities to dozens or hundreds of tests per sample is a major challenge, but this direction 
is progressing through the use of multi-layer microsystems (Martinez et al., 2010). However, 
this approach is unlikely to provide cell counts without major redesign.  
One fundamental design choice is the use of a disposable cartridge, which accepts the 
sample and contains the microfluidic network necessary for processing the sample, versus a 
reusable system, which would ideally reuse all of the microfluidic infrastructure.  In the 
latter case, only the sample itself and supporting additives would remain as biological 
waste. Those additives include the fluids required for flushing or cleaning the reusable 
device to remove all detectable traces of the sample and reagents. In contrast, the disposable 
cartridges encapsulate the biosample within its borders, simplifying the process of disposal 
while potentially eliminating the risk of cross-contamination. And, certainly, the disposable 
components could be designed to be more resource-conscious than current commercial 
designs. But even so, systems based on disposable cartridges will likely require more 
upmass for resupply than a reusable system would require. (“Upmass” is a term used to 
describe the mass occupied by something placed in a spacebound vehicle.) Close 
examination of the resources required by the device, the availability of flushing fluids and of 
upmass, the tolerance for risk, and the diagnostics requirements of the mission will 
determine the best approach for any specific space mission.  
A device designed for reusability can be more easily re-engineered to operate with a 
disposable, bioencapsulating cartridge than vice versa.  Consequently, in this work, we will 
examine the less studied problem of a reusable biomedical analyzer.        
www.intechopen.com
  
Biomedical Engineering – From Theory to Applications 
 
134 
There are many avenues for scaling down a biodiagnostic system’s footprint:   
 Reduce the scale at which the device operates. Operating volumes on the scale of several 
hundred nL have been proven. The need for effective pre-filtering is however essential. 
 Include onboard sensors and fluidics.  Optical and electrochemical detection are at this 
point reasonably mature.  Fluidic components such as micropumps and valving can be 
integrated with electronics for speedy communication and improved ruggedness. 
 Exploit shared resources, such as a PC for signal processing and display. USB ports can 
also be used to supply power that is adequate for well-designed systems.     
 Scale back the size of the disposable portion.  Examples include a disposable insert for 
sample retrieval following separation by capillary electrophoresis (Mohanty et al., 2006) 
or portions of a microperistaltic pump (Liu et al., 2003).   
 Incorporate  modularity, introduced into the system virtually through dynamic 
programmability, or physically by using quick disconnects or swapping out chips for 
different sample types or detection strategies (see §2.2). 
 Use systems that can perform massive multiplexing, i.e., process dozens to hundreds of 
diagnostic tests from a single sample (see §2.2 and §4.2).     
2.2 Flexibility, adaptability and modularity 
For space biodiagnostics, we would like to perform garden-variety blood and urine analysis, 
as well as more specialized tests. All testing will  involve counting particulates, such as cell, 
platelet, bacterial, and crystal counts, as well as detecting concentrations of dissolved 
substances in the sample, including gases, electrolytes, small molecules, and a range of large 
and small proteins (see §4.2). Due to the sheer number of assays to be processed, one key 
requirement will be the capacity for massive multiplexing on an individual sample. 
(“Multiplexing” simply refers to the capability of performing multiple measurements on the 
same sample.) The multiplexing should avoid “hard coding” an assay suite to the system to 
permit adaptability. Finally, we would like to extend the range of sample types to more 
broadly address the needs of physiological, biological and environmental analysis. 
Mix-and-match modules with simple connection strategies are one way to embed flexibility 
into a resource-conscious assay system. In one example, the development of “Zero Insertion 
Force” sockets allowed reconfiguration of the fluidic and electrical connectivity with up to 
60 independent electrical connections joined to a variety of microfluidic systems (Dalton & 
Kaler, 2007). For space diagnostics, a module for cell separation and counting could be 
coupled to a serum analysis module. The latter could be designed to operate on nL-scale 
volumes of well-filtered fluid. The blood pre-processor for cell separation and analysis could 
then be swapped out with a urine pre-processing stage, which would separate out solids 
content, while sending well-filtered urine on to the nanoscale detection device.  
Alternatively, dynamic flow control could be used to route the sample through different 
pathways to appropriate processing stations onboard a single chip. The basic principles of 
programmability that have become so integral to information technology are available for 
fluidic networks as well. In this case, the assay suite and the flow path can be specified at 
runtime, which can be effective at conserving reagents and streamlining operations. The 
rudiments of a Java interface were developed for operations on arbitrary portions of one 
biochip design, including metering, transporting, mixing, and purging (Urbanski et al., 2006). 
A device for studying protein precipitation included a Labview-driven system for quickly 
creating complex mixtures using 32 stock reagents in a 5 nL reactor (Hansen et al., 2004). The 
metering precision of 83.4± 0.6 pL ensured minimal reagent consumption. These approaches 
could add significant capability to a resource-conscious, adaptable biodiagnostic system. 
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Both of the strategies discussed above assume that reconfiguration requires the sample to 
access different sets of fluidic pathways, such as various reagent reservoirs, mixing devices, 
incubation chambers and/or detection stages.  In §4.2, we will discuss other approaches to 
massive multiplexing through assay design. 
2.3 Lifetime 
Devices and their supporting consumables must remain viable in a space habitat for years in 
an environment characterized by radiation exposure and low humidity, without dedicated 
hardware for sterilization or guaranteed access to refrigerated storage. This is a significantly 
higher bar than the requirements on shelf life for earthbound devices.  Moreover, little or no 
supply chain will exist for maintenance or replenishment. Therefore, NASA must find a 
solution with the right combination of physical and biochemistry, device and sensor design, 
and materials and fabrication choices to operate under the demanding conditions of long-
duration spaceflight.   
Like most commercial systems, the widely used i-STAT blood analyzer employs single-use 
assay cartridges. Its cartridges are rated by the manufacturer at a 4-6 month shelf life when 
refrigerated at 2-8˚C. NASA researchers found that some of the more common assays for 
blood chemistry retained their effectiveness for up to 12 months (Smith et al., 2004). No such 
testing is available for the single-assay cTNl cartridge, which detects troponin. This is 
problematic since the biochemical reagents in immunoassays are less stable over time than 
chemical reagents. Additional packaging to reduce the effects of gas diffusion and radiation 
exposure is likely to be the maximum effort that NASA could reasonably consider to extend 
the lifetime of commercial devices. See §4.2 for further discussion on assay design. 
Few studies explore the impact of long-term exposure to space radiation on shelf life. One of 
the only studies to address this issue is considered in a preliminary fashion by (Fernandez-
Calvo et al., 2006).  High doses of low-energy gamma radiation were not found to be 
significantly deleterious on antibody activity, which was contained in stabilizing solutions. 
However, the duration of exposure was not reported in this work, and shelf life was not 
addressed. Furthermore, the study does not address the type of radiation of most concern, 
i.e., that of large energetic particles, such as high-energy protons and neutrons emitted in 
solar flares. More work in this area would be valuable.  
Biochips must maintain geometric stability over their lifetime in space. Polymer chips are easy to 
manufacture, but are softer than silicon and glass, and may be more vulnerable in this regard. 
Cleaning and maintenance functions also impact this aspect of chip lifetime, particularly if 
disassembly is involved (Xie et al., 2005). Another concern is the degradation of seals, coatings, 
and sensing components, such as electrodes. Shelf life is certainly an issue for microscale 
electrodes (Shen et al., 2007; Zhang et al., 2007). Degradation could also affect overall 
containment in addition to sensing performance, and it could introduce fouling contaminants 
into the microfluidic network. The latter is of most concern when the contaminant is 
introduced downstream of filtration. One solution is to use techniques that isolate degradable 
sensors like electrodes from contact with fluids in the device (Nikitin et al., 2005). 
Operational lifetime will be a function of the underlying (bio)chemistry, the biochip design, 
and the environment in which the sensor operates. In the literature on biochips, operational 
lifetime is occasionally reported, particularly for reusable immunoassays with expensive 
antigens or other biological recognition elements, since binding kinetics can degrade with 
cycling. Some studies report adequate function with some reusability  (Chen et al., 2003; 
Yuan et al., 2007), depending on storage conditions. In spaceflight, devices must be stable 
for several years with hundreds to thousands of uses. 
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2.4 Gravitational independence 
Mars exploration requirements prompted the development of biochip-based solutions for 
detection of organic acids using capillary electrophoresis (Skelley et al., 2005), which 
integrated power, pneumatic control and optics. Some microdiagnostics for biology have 
been tested in specially outfitted aircraft in parabolic flight campaigns. In this reduced 
gravity environment, a sequence of roughly 40 parabolic trajectories are traversed.  At the 
peak of each parabola, 20-25 seconds of microgravity can be attained.  Such testing provides 
insight into behavior on the Space Station, in which the net quasisteady acceleration is 
typically on the order of a few μg (where 1 μg=1x10-6g), although there can be much larger 
vibrational and transient disturbances (Nelson, 1994). Microfluidic devices that have 
undergone parabolic flight testing include electrophoretic separation of amino acids in an 
aqueous environment (Culbertson et al., 2005), an immunoabsorbent assay (Maule et al., 
2003), and more recently, a blood analyzer on a reusable microfluidic platform (Chan et al., 
2011). 
We should not expect large variations in biochemistry (e.g., the biokinetic constants that 
describe binding processes) over short periods in reduced g. However, we should anticipate 
altered heat and mass transport due to differences in fluid behavior. Gravity and other 
accelerations act on density differences to drive processes such as sedimentation, bubble 
migration and natural (buoyancy-driven) convection. As we decrease the size of fluidic 
channels, we create a system with an increased surface-to-volume ratio, which in turn 
changes the relative importance of the forces that drive fluid transport. Macroscale systems, 
such as separation of plasma from whole blood through centrifugation, are governed by 
volumetric forces such as gravity and centrifugal acceleration acting through density 
variation to produce the separation. In microfluidics, surface forces, such as friction and 
surface tension, become more important. Nevertheless, we must also consider the altered 
competition of intermolecular forces leading to observed binding kinetics between 
neighboring surfaces and the bulk liquids in microfluidics devices. Both molecular 
orientation changes and direct molecular attraction/repulsion through surface coatings 
could potentially influence overall assay results if bulk transport is affected in microgravity.   
In microgravity, particles are less likely to sediment in any static system, but bubble 
management can become more challenging. Processes that require large liquid/vapor 
interfaces to generate bulk flows in liquid will operate in an even less intuitive manner in 
microgravity. In space, surface-tension forces dominate liquid/vapor interface behavior 
without the application of other forces, creating blobs of liquid in unconfined space, or fully 
wetted surfaces with an interior bubble in enclosures.  To be prudent, processes that can 
create bubbles must be analyzed for microgravity operation before use in space. In some 
cases, bubble generation is fundamental to the technique (Satoh et al., 2007; Furdui et al., 
2003) and in other cases, bubbles can be an unintended consequence, e.g., of hydrolysis 
(Lancaster et al., 2005). Metabolic processes or biochemical reactions can create dissolved 
gases. Temperature and/or pressure variation can thermodynamically drive dissolved gases 
out of solution. Over time, liquid evaporation and gas diffusion through seals or porous 
materials can cause gaseous pockets to form in a liquid-filled device. Wherever there is a 
discontinuity in the fluid path, the potential for bubble generation exists.  The location at 
which the sample meets the microfluidic device is one such juncture.   
These considerations are of interest because bubbles can effectively clog the pathways of a 
microfluidic device and/or interfere with the detection process. The consequences are more 
serious for a device in space because bubbles are less inclined to migrate to specific 
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locations, such as the top of the device, for easy removal. One strategy is to prime the 
biochip system on earth so that all bubbles are removed before leaving for space. For short-
term usage in carefully designed systems, this may provide adequate bubble control, but for 
long-duration flight, it is probably insufficient. Application of a large pressure gradient is a 
brute-force method to clear the fluidic channels of bubbles. As the channel dimensions 
decrease in size, the pressure gradients needed to drive bubbles out of the device increases, 
particularly for microfluidic channels with torturous geometry. A recent parabolic flight 
experiment demonstrated that a net pressure difference of about 10 kPa was sufficient to 
clear even large bubbles of air through channels with a cross-section of 200x120 m2 (Chan 
et al., 2011), although this device was intentionally designed to avoid channel features that 
could become bubble traps. Wetting properties in microchannels can be affected by 
surfactants, which can reduce the resistance to flow caused by bubbles (Fuerstman et al., 
2007). Another strategy is to propel bubbles out of the system through the use of gradients 
in wetting properties of the walls, created through active control of an electrical field 
(§3.2.1). For our purposes, unless a device employs electrowetting for other purposes, it is 
not worth including it if application of pressure is adequate. 
While the density ratio of most vapors to aqueous solutions is on the order of 1000:1, the 
density variation between typical biological liquids and particles is just a few percent, so the 
effect of gravity is less significant than for bubbly liquids. However, even at the scale of 10-
100 m, buoyancy and drag can affect particle behavior in electromagnetic sorting (Furlani, 
2007) and microvortex cell trapping (Hsu et al., 2008), indicating that microgravity 
sensitivity should be examined during the design of biodiagnostics.   
3. Hardware design 
This section focuses on chip design, flow actuation, separation, mixing, and transport to the 
detection stage for space applications. To operate in the real world, devices must respond to 
the properties of real samples, so we begin with a discussion of sample properties. 
 
 
Fig. 1. Length scales of components commonly found in blood and urine samples. 
3.1 Sample characteristics 
Blood is a mixture of ~55% plasma by volume with ~45% solids content, comprised of  
red blood cells (erythrocytes), white blood cells (leukocytes) and platelets (thrombocytes, 
which are the least dense type of cell). The number density of leukocytes is typically 100-800 
times less than that of erythrocytes. These cells form the raw material for measurement  
of hematocrit (volumetric fraction of erythrocytes in blood), counts of erythrocytes, 
leukocytes, platelets and hemoglobin content. Leukocytes are further distinguished into  
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 Shape size (m) deform-
ability 
density 
(kg/m3) 
count 
(number/L) 
suscepti-
bility (SI) 
erythrocytes 
biconcave, 
discoid 
diameter 
~8.5  
thickness 
~2.3
high 1100 3.5-5.5x106 
-9.22x10-6 * 
-3.9x10-6 ** 
leukocytes Spherical 
diameter 
~6-15
low 1070 3.5-11x103 -9.2x10-6 
platelets 
platelike or
irregular
1-3 high lower 1.5-4.5x105  
Table 1. Properties of blood cells.  Data from (Furlani, 2007) and (Wikipedia, 2011). 
*deoxygenated, **oxygenated 
five basic subtypes. The number density of these white blood cell subtypes vary widely in 
the blood, as do their size and structure. The least populous subtype, basophils, are found in 
concentrations of 40-900 cells/L (Wikipedia, 2011), so that the required sample volume 
may be larger than a single drop of blood to derive meaningful statistics. More detailed 
subtyping on rarer white blood cells can provide even more specific diagnostic information, 
such as the presence of particular cancers or other pathologies. There is much diagnostic 
value in such information, so significant effort is placed on separating white blood cells and 
specific subtypes from whole blood. Fortunately, blood cells differ significantly in size, 
shape, deformability and electrical properties, as shown in Table 1 for healthy adults. As a 
rheological fluid, the viscosity of whole blood is a function of shear rate and other 
environmental factors. Its viscoelastic behavior derives primarily from erythrocyte 
deformability. Blood viscosity is also dependent on its composition and can be correlated to 
hematocrit and fibrinogen content. Depending on shear rate, the mean whole blood 
viscosity in healthy people varied from 3.2 to 5.5 mPa·s in one study.  With blood cells 
removed, plasma viscosity decreased to 1.4 mPa·s (Rosenson et al., 1996). As with whole 
blood, plasma viscosity can be correlated to composition, specifically to fibrinogen, total 
serum protein and triglycerides (Rosenson et al., 1996). Plasma is primarily composed of 
water, but also contains essential salts; ionic species such as calcium, sodium, potassium and 
bicarbonate; and larger molecules such as amino acids, lipids, and hormones and other 
proteins. Serum is produced from blood plasma by adding anticoagulant, such as 
ethylenediaminetetraacetic acid (EDTA). Serum is desirable for most assays, with some 
exceptions such as clotting assays (Hansson et al., 1999). 
Platelets are normally platelike in shape, but when activated, they become rounder and long 
filaments protrude from their surface (Fig. 2(b)). In this state, platelets readily clump 
together, or aggregate, forming connections via two key proteins, fibrinogen and von 
Willebrand Factor (vWF). The latter is contained in endothelial cells of blood vessel linings 
as well as in granules inside platelets. The combination of shear stress and vWF are key 
players in platelet activation. Shankaran and co-workers identified two stages: one in which 
the presence of high fluid shear and vWF sensitize the platelet to shear. At later times, 
platelets can become activated at much lower shear stresses and without the presence of 
vWF (Shankaran et al., 2003). The process is only weakly dependent on local platelet 
concentration, indicating that it is fluid shear acting on individual cells, and not cell 
collisions, that govern the process.  Following exposure to a threshold fluid shear stress  
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= 75 dynes/cm2, they found that a suspension of isolated platelets with viscosity  
=1.1 mPa·s was significantly more likely to become activated (similarly for whole blood at 
=83 dynes/cm2, =3.8 mPa·s). Even a few seconds of exposure can be sufficient to sensitize 
platelets (Dayananda et al., 2010). The viscosity of the fluid medium is important because it 
is the shear stress, not the shear rate reported in many studies, that governs the behavior.  
(In a homogeneous fluid, shear stress is the shear rate multiplied by viscosity.) Clearly, the 
microfluidic design must avoid such levels of shear stress. But given the dependence on 
shear stress history, the sample should avoid wall proximity to limit the potential for 
adhesion. This is a strong argument for rigorously avoiding fluid separations (recirculating 
flow cells), which may occur near sharp bends, corners, and steps. It also suggests that 
sample dilution can be beneficial by lowering fluid viscosity and reducing protein and cell 
concentration.     
 
 
Fig. 2. Solids found in blood and urine samples: (a) blood cells; (b) erythrocyte, activated 
platelet, and leukocyte; (c) urinary erythrocyte cast; (d) calcium oxalate crystals (arrows)  
(e) uric acid crystals; (f) triple phosphate crystals with amorphous phosphate.   
(a)-(b) reprinted from the National Cancer Institute, Frederick, Md.; (c)-(f) reprinted from 
the National Institutes of Health Clinical Center Department of Laboratory Medicine, 
Bethesda, Md. 
Urine separation presents a different set of challenges. Although the solids content is far 
less than blood, the size and other properties of the particulates vary more widely. These 
can include cells, casts (which include blood and tissue cells that have passed through the 
renal system, retaining the renal tubule’s shape, Fig. 2(c)), proteins, and a wide array of 
crystals (Fig. 2(d)-(f)). Size, electromagnetic properties, rigidity, and staining propensities 
are also quite variable. Obtaining well-filtered urine should be straightforward with 
branching techniques (§3.2.2). Examination of urinary sediment can also yield critical 
diagnostic information, but it is somewhat more challenging to accommodate in a 
microfluidic context. Typically, a urine sample of 10-15 mL is centrifuged at ~2000-3000 
rpm for five minutes to concentrate the solids content. Pure fluid is withdrawn until ~0.2-
0.5 mL remains. A drop of this fluid is then examined under a microscope (Simerville et 
al., 2005). To examine urinary sediment in the space environment, an effective 
microfluidic concentrator would be required as well as a means of staining and imaging 
the concentrated sample.    
Saliva is of interest to space biodiagnostics because of its ready availability and marginal 
invasiveness to the astronaut, particularly since wound healing proceeds more slowly in 
space (Delp, 2008). Saliva’s non-Newtonian viscoelastic behavior is a result of its high mucin 
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concentration, which makes it a challenging fluid for microfluidic applications.  In one 
study, pre-processing the saliva via filtration through a 0.2 m membrane was found to 
remove 92% of total proteins and 97% of the mucins, so that treated saliva could be analyzed 
in a microfluidic sensor (Helton et al., 2008). However, sensor fouling still remained an 
issue. Another study used a commercially available sorbent within a microdevice as a 
preparatory stage for microscale capillary electrophoresis to concentrate hydroxyl radicals 
while removing undesirable saliva components (Marchiarullo et al., 2008). While these pre-
processing stages are not compatible with reusability, they may provide an avenue to pre-
processing saliva for use in a reusable device.     
Other sample types of interest include examination of potable water for toxin and bacterial 
content, animal fluids and cell cultures, for which the strategies discussed above are 
applicable.  Throughout the rest of this document, the term “analyte” or “target” refers to 
the component of the sample that is to be analyzed. An “assay” is simply a test performed 
on a sample to yield information on the desired target. 
3.2 Chip design 
For a reusable device, the potential for cross-contamination is a major concern.  Designs 
should therefore minimize residence time of the sample near the walls to minimize the 
opportunity for adsorption.  In general, channels of uniform height without sharp bends, 
steps, expansions or contractions will have less opportunity to form stagnation zones that 
could increase sample residence time near the walls.  A continuous, uniform flow rate also 
limits the potential for fluid eddies that could bring the sample into contact with the wall. 
(On the other hand, devices with unavoidable and persistent stagnation zones could benefit 
from periodic disruption by pulsatile flow (Corbett et al., 2010.)) Unless a competing design 
presents substantial advantages and minimal compromises in operation and lifetime, this 
should be the baseline design of a reusable microfluidic device.   
In general, passive processes are preferred for space applications in order to reduce power 
consumption. The most robust system will have no moving parts, simple geometries, and 
simple flow controls. Meeting this goal may involve relatively simple design tradeoffs in 
separation and mixing processes (§3.2.2), but it is more difficult for flow actuation (§3.2.1). 
From §3.1, it is clear that for reusable microfluidics, it is advantageous to avoid sample 
contact with walls. Consequently, droplet-based processing will not be included in this 
discussion. Sheathing, which surrounds a sample by flowing streams of inert liquid such 
as buffer, is one means of separating the sample from the chamber walls. This strategy is 
routinely employed in flow focusing (§3.3). If the sheathing fluid does not mix effectively 
with the sample, one study showed that the sheathing fluid could even be recycled in an 
automated fashion (Hashemi et al., 2010). Another microfluidic device encapsulated plugs 
of aqueous analyte in oil to prohibit sample contact with the biochip surface (Urbanski et 
al., 2006). Oil and water are examples of two fluids that are immiscible, i.e., they do not 
mix, but instead maintain a sharp interface.  
3.2.1 Flow actuation and control 
Fluids handling requires effective means of actuating (initiating) flow, priming, pumping, 
metering, separating, mixing, and flushing. There are many options for initiating fluid 
motion in microfluidics. Capillary forces are sufficient to draw blood into a glass 
micropipette. While this technique could be used to introduce blood into the device, it is 
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generally insufficient to pump fluid through a microfluidic device (with some notable 
exceptions (Martinez et al., 2010).) Mechanically, the simplest way to drive flow is through a 
hydrodynamic pressure difference, produced by connecting the inlet and exit ports to fluid 
reservoirs of different heights (Shevkoplyas et al., 2005; Simonnet & Groisman, 2006).  A 1-m 
difference in water column height between two reservoirs translates to an overall pressure 
drop of 10 kPa, which is sufficient to drive flow in an uncomplicated microdevice. This 
might also be an option on the lunar and Martian surfaces, after taking into account their 
reduced gravity to roughly 1/6th and 2/3rd earth gravity, respectively. 
Pressure-driven flow can also be actuated with syringe pumps.  Although they represent  
an unacceptable penalty on mass, volume and power resources for space diagnostics,  
they provide reliable, precise control over the flow rate on earth.  A manually operated 
syringe for driving flow is feasible for space operations, but flow control would be more 
difficult. 
Mechanical micropumps include centrifugal, peristaltic, reciprocating and rotary pumps. 
Displacement pumps apply forces to move boundaries, which in turn move fluid.  One 
example of this class is peristaltic pumping, in which three or more pumping chambers are 
squeezed in a deliberate sequence with an actuating membrane.  Reciprocating pumps 
initiate flow in a pressure chamber through actuation of a diaphragm. Rotary pumps move 
fluids by means of rotating, meshing gears.  All of these standard techniques for actuating 
fluid have counterparts at the microscale, but there are also additional options available.  
Below we describe some of the more intriguing microfluidic flow actuators that could be 
suitable for space. 
Microfluidic networks built on a rotating disk can operate without internal moving parts, 
using centrifugal force as the sole means of flow actuation (Madou et al., 2006). Many such 
systems conform to the size of compact discs and can even be used in a conventional CD 
drive. The current convention is a disposable “lab-on-a-CD” with single-use membranes 
acting as valves, but this design could conceivably be made reusable with appropriate 
valving, extraction and flushing functions.  Recent innovations with such devices on larger-
scale samples (Amasia & Madou, 2010) could make this technique a design choice worth 
considering for urinary solids concentration. 
Bubbles can be used as a type of displacement pump, since they displace liquid during 
controlled growth. Hydrolysis can be used to generate bubbles with precision to drive flow 
in a microfluidic channel (Furdui et al., 2003). Deliberate creation of bubbles within a 
microfluidic device for space, however, should be considered with caution, since bubble 
management is not a trivial matter. 
Other electrically based methods include electrocapillary or electrowetting micropumps, 
which use an electrical field to dynamically modify the surface charge, thereby controlling 
the local surface tension. Surface-tension gradients can be generated in a manner that 
mimics peristaltic pumping.  Electrokinetic pumps use electrophoresis and electroosmosis to 
drive flow. All can be effective in microdevices, since they can be designed to operate at low 
power and without moving parts.  There are a variety of commercial and research-level 
micropumps and microvalves based on these principles.  These techniques represent a 
viable alternative to micromechanical actuation, but bubble control, surface stability and 
gravitational independence must be demonstrated over a long lifetime.   
Timing, valve control, and well-controlled mixing over a long lifetime are going to be 
essential features of a successful device.  If tight precision on metering, mixing and splitting 
is needed, one solution with easy computer interfacing may be found using solenoid 
www.intechopen.com
  
Biomedical Engineering – From Theory to Applications 
 
142 
actuators that pneumatically control elastomeric valves. One such device reliably 
manipulated sample volumes down to 5.7 nL (Urbanski et al., 2006).   
3.2.2 Microfluidic channel design 
The microfluidic network must accept the sample and supporting fluids, perform sample 
pre-processing such as separation or concentration, provide a means of mixing the sample 
and reagents or other additives, and transport the fluid to the detection region.  For reusable 
devices, they must also have associated flushing operations performed in them.  
Mixing can be achieved passively by introducing texture to walls, placing obstacles in the 
flow, splitting and recombining fluid streams, or introducing curvature. When two miscible 
fluid streams are introduced into a single microfluidic channel, the fluids will mix spontan-
eously via molecular diffusion as they traverse downstream. However, this can require a 
very long distance because diffusion is a very slow process. Complete mixing over a shorter 
length can be achieved if additional incentives are introduced, such as convective motion. 
Convective mixing is added through geometry by channel bending, twisting, and flattening 
(MacInnes et al., 2007). However, these convoluted flow paths come at the price of increased 
flow resistance, which imposes increased power requirements (Hsu et al., 2008).   
Modification of wall geometry was used to improve immunoassay performance through 
mixing enhancement (Golden et al., 2007). In this case, antibodies were immobilized at the 
bottom sensor surface. The target protein was captured from the sample stream as it 
bound with the antibodies, resulting in a layer of increasingly target-poor solution next to 
the sensor downstream. By adding grooves at the top of their channel, they promoted 
mixing over the entire cross-section of the channel. Increased mixing resulted in better 
delivery of fresh analyte to sensor surface. Other studies have examined in detail the 
effect of such surface modifications on flow profiles (Howell et al., 2005). Surface 
patterning can provide effective mixing, but it adds complexity to the fabrication process, 
and may slightly increase the necessary driving force to move fluid through the system. 
Most critically for reusable devices, they must be evaluated for fouling potential in the 
vicinity of the patterning.   
Diamond-shaped obstacles force the flow to break up and recombine, providing good 
mixing at low power over a broad range of flow conditions (Bhagat et al., 2007). The sharp 
leading edge acts to separate the fluid streams.  The design also provides a potential location 
for a stagnation zone just downstream of the sharp corner at the widest portion of the 
diamond.  In the laminar flows that are typical of microfluidics, such expansions can 
generate flow separations if the expansion angle exceeds 7° (Panton, 1984). Substituting a 
slimmer biconvex shape could reduce this proclivity, but it would also reduce the intensity 
of mixing.  The mixing becomes less vigorous by decreasing the span of the obstruction and 
hence the amount of fluid lateral motion. By eliminating the separated zone next to the 
obstacle, we have limited the region of increased mixing to strictly downstream of the 
obstruction. This option increases geometric complexity only slightly, although it introduces 
new walls into the system. For reusable systems, the fouling potential must be evaluated on 
the surfaces of the obstruction and weighed against gains in mixing efficiency. 
Another technique for passive mixing without tortuosity, splitting, obstructions or surface 
roughness is through the introduction of curved channels.  As fluid rounds the bend, 
centrifugal forces drive Dean flow, evidenced in secondary flow structures in the form of 
two counter-rotating vortical structures along the flow direction that span the channel 
cross-section. Frictional drag on a given particle is proportional to its effective radius in 
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the flow direction and the net acceleration acting on the particle.  Through this 
mechanism, the mere presence of the curved channel can serve to drive size-based particle 
separation (Di Carlo, 2009). Any relative motion between the particle and its carrier fluid 
should also serve to provide additional fluid mixing. This design is attractive for 
reusability because it enhances mixing without requiring geometric features that 
introduce fouling potential. In a recent example, a spiral architecture was a core design 
principle of a reusable blood analyzer prototype for space (Chan et al., 2011).  
Electrokinetics-based techniques in mixing (Chang et al., 2007) generally require more 
attention to lifetime for space applications, since their function is dependent on surface 
properties and treatments, which can degrade over time (Mukhopadhyay, 2005). Valve 
functions can be lost due to contamination during usage, although surface geometry can be 
an aid in this regard (Nashida et al., 2007).  Finally, these techniques may not have the same 
level of control as micromechanical metering (Urbanski et al., 2006).  
Careful filtration reduces the likelihood of introducing fouling contaminants to the system, 
which minimizes clogging and simplifies post-test cleaning.  Filtration may be necessary at 
multiple length scales in sequential stages, based on the constituents in the sample and the 
assay under consideration. By removing unnecessary components from the sample, it can 
have the added benefit of improving the signal-to-noise ratio due to nonspecific response in 
the detection stage. On the other hand, filtration could also remove large molecules, such as 
some proteins, that may be the target of a particular assay.  
Filtration techniques range from brute-force mechanical trapping to elegant biomimetic 
capture. For filtration in reusable devices, continuously flowing techniques are preferred to 
mechanical trapping. All separations exploit variations in size, density, deformability, 
biokinetic and electromagnetic properties among the blood components. In the systems in 
Fig. 3, blood cells are preferentially directed into specific channels, but are not trapped nor 
are they subjected to vigorous mechanical forces that could cause cell lysis, or rupture.   
Plasmapheresis is the process by which plasma is separated from whole blood. Fig. 3(a) 
demonstrates the utility of simple bifurcations to extract pure plasma (Yang et al., 2006). 
Processing time could be reduced by adding pulsatile flow (Devarakonda et al., 2007), but 
the increased complexity and fouling potential may be of concern for space diagnostics. 
Another design option is to send the entire fluid stream through a constriction followed 
by an expansion. In this case, a cell-free layer develops next to the downstream walls, the 
extent of which is a function of the length and width of the constriction, as well as the 
flow rate (Faivre et al., 2006). Gentle contraction and expansion flows may serve to further 
segregate the cells from the walls while providing a plasma-rich region nearer to the wall 
close to the branch points.   
Prototypes for separation often use inorganic analogs for blood cells as a starting point.  
Although a reasonable analog for leukocytes can be found in appropriately sized and 
weighted rigid spheres, erythrocytes are neither spherical nor rigid. Studies that carefully 
design geometries and flow rates to separate out differently sized spherical particles are 
likely to miss the mark when extrapolating to real-life blood cell separation. Dense 
suspensions of rigid particles in flowing fluid tend to have a high concentration of the 
smallest particles immediately adjacent to the boundaries. However, hydrodynamic forces 
acting on deformable, biconcave erythrocytes drive them to the fastest-moving region of 
flow, although they are smaller than leukocytes. Consequently, in bifurcating flow  
(Fig. 3(b)), erythrocytes preferentially choose the higher velocity bifurcation (Yang et al., 
2006).   
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Fig. 3. Continuous flow separation techniques: (a) plasmapheresis through branching 
channels, (b) erythrocytes exhibit a preference for the faster moving stream, (c) detail of 
branching technique for leukocyte enrichment from whole blood using the network of (d) 
leukopheresis geometry for 34x enrichment; (e) leukopheresis geometry for 4000x 
enrichment. (a)-(b) reproduced with permission from (Yang et al., 2006), copyright 2006, The 
Royal Society of Chemistry; (c)-(d) reproduced with permission from (Shevkoplyas et al., 
2005), copyright 2005, American Chemical Society; (e) reproduced with permission from 
(VanDelinder & Groisman, 2007), copyright 2007, American Chemical Society. 
Blood flow exhibits Poisseuille (parabolic) velocity profiles in microchannels. Erythrocytes 
favor the faster-moving flow at the center of the channel rather than the slower-moving 
fluid near the walls. As these cells migrate to the center of the channel, cell/cell collisions 
tend to drive leukocytes toward the channel walls. The design in Figs. 3(c) and (d) ensured 
that all of the collisional energy among blood cells was dedicated to driving leukocytes to 
the walls, providing efficient locations for siphoning off cells (Shevkoplyas et al., 2005). This 
clever biomimetic technique operated effectively without sample dilution and with simple 
process control for minimal resource consumption. The lack of dilution and the reliance on 
collisions may impact fouling potential, however.  
Excellent performance in leukocyte separation from whole blood was demonstrated in the 
device in Fig. 3(e), without fouling over an hour in continuous use (VanDelinder et al., 
2007). In a single pass, the ratio of white to red blood cells at the outlet showed a 4000-fold 
increase. The simpler design shown in Fig. 3(d) showed more modest leukocyte enrichment 
of 34 times (Shevkoplyas et al., 2005). However, both designs beat “buffy coat” preparation 
produced by single-spin centrifugation, which provides 10-20 times enrichment. The 
geometrically complex design of Fig. 3(e) features channels of varying height which 
intersect at right angles, and requires flow control. Contrast this to Fig. 3(d) which exhibits 
uniform height, minimal branching at gentle angles, and is driven by a single pressure drop 
over the entire system. Either design provides adequate enrichment for simple leukocyte 
differentiation. Space biodiagnostics favors devices that provide adequate function with 
minimal resources and simple geometries.  
Another common method of enrichment uses an array of micropillars strategically placed in 
the channel (Chang et al., 2005). The physical obstructions preferentially slow down leuko-
cytes without stopping them completely, thus providing enrichment. Many other separation 
techniques also rely on hydrodynamic principles to separate cells from blood. Electrokinetic, 
electroosmotic, dielectrophoretic and magnetic forces can also be used for active separation, 
discussed in depth elsewhere (Lenshof et al., 2010; Salieb-Beugelaar et al., 2010).  
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3.2.3 Materials choices and fouling considerations 
Most prototype biochips are created from materials that are easy and inexpensive to 
manufacture, particularly polydimethylsiloxane (PDMS). However, such polymers readily 
absorb small molecules that can interfere with fluorescence measurements (Toepke & 
Beebe, 2006) as well as nonspecific proteins (Mukhopadhyay, 2005). To mitigate this 
unfortunate property, surface treatments such as plasma exposure can be used to create a 
hydrophilic surface. This treatment also improves surface bonding. A great deal of effort is 
devoted to design of low-fouling surface coatings, but they may not survive in 
microdevices requiring use over a long lifetime (Balagadde et al., 2005; Mukhopadhyay, 
2005). In addition, the non-negligible permeability of polymers to gases imposes the need 
for good strategies for fluids priming, flushing and bubble control, since liquids within a 
polymer device will evaporate over time.   
More promising materials include silicon and glass, which are less surface-active and less 
permeable to gases. They maintain integrity over a longer lifetime, and geometric details can 
be more tightly controlled, especially with silicon. They are, however, more expensive to 
manufacture (Han et al., 2003). In order to use a glass biochip safely on the Space Station, it 
must have containment that filters particulates down to 50 m (International Space Station, 
2002). Silicon presents some unusual design possibilities by providing bounding walls that 
can be dynamically charged to change wetting and adsorption properties. In one design, 
which also included a low-fouling polymer layer, a controlled electrostatic attraction pulled 
proteins from solution onto the wall reversibly (Cole et al., 2007). This technique could 
potentially be used to concentrate urinary protein for detection, filtration, or flushing (with 
the usual caveats for addressing lifetime and cross-contamination issues).  
Regardless of materials choice, it is beneficial to minimize contact between the sample and 
the wall or sensor to reduce the potential for fouling.  To avoid wall interaction entirely, one 
strategy is to encapsulate the aqueous sample in an immiscible fluid (Urbanski et al., 2006).   
Aside from fabrication challenges and gas permeability, another concern is the degradation 
of biochip  components, such as electrodes (Chen et al., 2003; Shen & Liu, 2007; Shen et al., 
2007; Zhang et al., 2007), which may interfere with detection performance, release 
contaminants into the device, or affect containment. In some cases, electronics can be placed 
outside of the channel to prohibit contact between the sample and the sensor (Nikitin et al., 
2005). Processes that employ electrical or magnetic fields to drive, mix or separate fluid 
streams can also be designed to avoid contact of the control elements with the sample.  
Materials choices, surface treatments and coatings, the type of reagents and samples can all 
influence device lifetime and performance.  Silicon and glass are good working materials for 
producing a long-lived, reusable microfluidic device.  Polymers are less suitable candidates 
for space diagnostics due to higher gas permeability, greater potential for fouling, and 
reduced geometric integrity. Electrodes and other biochip components must not degrade 
over a lifetime of several years and hundreds to thousands of uses. 
3.3 Detection strategies 
The primary functions of biodetection are to count particles, detect and/or quantify 
concentrations of dissolved compounds and visualize particulates. Detection techniques can 
be based on direct sensing or may require an intermediate step for labeling, binding, or 
chemical reaction.  To minimize reagent usage, reduce sample residence time and fouling 
potential, reusable design has a strong bias towards detection schemes requiring short 
incubation periods, fast reaction kinetics, and short detection times.  
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Since there are many comprehensive reviews cited in §1 and elsewhere that cover the field 
in great depth, we will focus on optifluorescent detection, which provides great versatility in 
designing assays using a single detection modality, for both cell counting and massively 
multiplexed biomarker detection. The popularity of this technique has prompted 
development of multi-channel laser systems, which increase the multiplexing potential.  The 
capability to differentiate many targets simultaneously is enhanced by recent developments 
in assay development, discussed in §4.2.     
An impressive differentiation of all 5 leukocyte subtypes was recently achieved by Tai 
and co-workers (Shi et al., 2011).  Their approach is based on strategic choice of three 
fluorescent dyes which stain proteins, nucleic acids, and cytoplasm contents. The 
resultant fluorescent signatures are sufficient for a two-channel laser detection system to 
discriminate among all the cell types.  This approach was tested on 5L human blood 
samples, spiked with purified basophils due to their rarity in whole blood. The 
differences in the cell’s internal structures cause the uptake of the dyes to be 
proportionally different for each cell type. A scatter plot of red vs. green fluorescence 
intensity produces 5 distinct regions, which correlate to the 5 cell types. Data points in 
each cluster are counted to enumerate the number of cells in each category.  The resulting 
measurement agreed well with a commercial assay system in terms of cell subtype 
percentages as well as overall leukocyte count. In operation, the blood sample will be 
acquired through a needle integrated with a disposable cartridge, which interfaces with 
their portable microcytometer. They deliberately designed the system to avoid the need 
for diluents, which keeps the chip size small.  By encapsulating the sample within the 
chip, the biohazardous waste from sample acquisition and processing is contained and the 
possibility for cross-contamination minimized or eliminated.   
In some cases, visual examination of microstructural detail can add enormous insight into 
the physical, biological and physiological processes of interest. The International Space 
Station hosts the Light Microscopy Module, which can perform high-resolution color video 
microscopy, brightfield, darkfield, phase contrast, differential interference contrast, 
spectrophotometry, and confocal microscopy.  Options include custom-designed laser 
tweezers for sample manipulation and remote control from earth at NASA Glenn Research 
Center. Experiments using the device began in March 2011 as this is being written. No 
results are yet available, but human blood will be one of the early samples examined. These 
capabilities bring the power of a state-of-the-art terrestrial imaging facility to the Space 
Station, continuing NASA’s shift in focus from ground-based analysis of space-exposed 
samples to in situ analysis in microgravity. 
To facilitate ease of use and expand capabilities for bioanalysis, Todd and co-workers are 
developing an observation platform to interface with the Light Microscopy Module, which 
adds a substage illuminator and epi-illumination (Todd, 2009). Onboard controllers and 
actuators can be used to exchange fluids between two small chambers on the platform to 
initiate a process, fix biological samples or retrieve suspended cells. This device could be 
used for cell counting and detailed visual examination of cell and plant cultures, animals 
and human blood, urine, and water samples.  
4. Operational design 
To function effectively in a space habitat as a general-purpose laboratory, a reusable 
microfluidics-based biodiagnostic must include strategies for sample acquisition (§4.1), 
incorporation of new assays (§4.2), and effective flushing/cleaning operations (§4.3). 
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4.1 Sample acquisition and transport to the microfluidic device 
As with any biological diagnostics, protocols for sample acquisition must be established to 
ensure reliable, repeatable measurements, including skin cleansing to remove potential 
contaminants as well as efficient, non-contaminating sample acquisition and transport to the 
microfluidic channels of the biochip. To reduce invasiveness to the astronaut, acquisition of 
capillary blood is preferred to a venous blood draw. Resource-conscious fingerprick devices 
for space are under development (Chan, 2009). Biohazardous waste from sharp needles can 
be reduced through the use of microneedles, which are also better at reducing invasiveness 
and pain. But they require a means of transporting the sample to the chip in a sterile, bio-
contained fashion.  For our purposes, the flow driver for sample transport could be 
integrated into either the lancet/needle side or the device side of the system, depending on 
which design is most compact or practical. Actuation drivers can be placed on the 
biodiagnostic device, acquisition device, or both, to supplement capillary forces in bringing 
the sample onto the biochip. Since there is a discontinuity in the fluid path at the junction of 
the sample transport device and the chip, acquisition is a key element in device design for 
bubble-free operation.  
Acquisition and transport of a urine sample in space can be a messy procedure. From the 
standpoint of reusables, the best option would be integration of sample collection with the 
urine collection system on the spacecraft. Since urine has a much lower solids content than 
blood, acquisition of a well-filtered fluid sample should be simpler than for blood.  
Examination of urinary sediment would require a means of concentration. Branching 
techniques as used for plasmapheresis in §3.2.2 could be considered. More efficient 
concentration could be achieved with micro- (or milli-) centrifugation (Amasia et al., 2010). 
Following sample acquisition, any nondisposable components will require cleaning to 
return it to a clean state.  It may be impractical to clean some components, particularly those 
at the smallest scale. In this case, the next best goal is to minimize the disposable part of the 
system. 
4.2 Assay design 
Assay development is going to be one of the limiting factors in realizing the full capabilities 
of a massively multiplexed biodiagnostic device.  Techniques that require no additional 
staining, labeling or binding agents are particularly attractive for space use, but a general-
purpose system will not be able to avoid the use of additives. For example, opportunities  
to exploit autofluorescence are only available for a few targets. The biokinetics of  
some immunoassays are reversible in principle, but performance degrades after a number  
of binding and unbinding cycles, although gains have been recently made (Choi & Chae, 
2009). The least attractive option for space diagnostics is to introduce single-use reagents 
into the system, but it is unavoidable considering the need for a reasonable range on the 
assay suite.   
The sensitivity and specificity of a given assay will be a function of (bio)chemistry, sensing 
modality, design and calibration standards, and the fluid matrix in which the target is 
embedded (Vesper et al., 2005a; Vesper et al., 2005b), as well as the fabrication process.  In 
designing a system that can be used for blood, urine and other sample types, some system 
efficiencies can be realized through the existence of common assays.  For example, 
measurement of glucose is specified in the crew health requirements for both urine and 
blood.  Moreover, from a medical standpoint, diagnostic value may be improved when both 
serum and urine data are available, e.g., for osmolality (Pagana & Pagana, 2005).   
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When reagents are needed, wet chemistry is the most widely used approach for blood 
analyzers. Stability can be improved by reconstituting dried reagents at runtime (Chen et al., 
2005), microencapsulation techniques (Sahney et al., 2006), and stabilizers, particularly in the 
case of immunoassays (Guire, 1999; Park et al., 2003). Dry chemistry is likely to have the best 
payoff in the stability of biological recognition elements, such as antibodies. This is the 
approach taken in urinalysis test strips, e.g., Chemstrips, that have a shelf life of one year 
after opening the package. Reconstitution of soluble reagents or tethered molecules at 
runtime is unlikely to present any microgravity-related issues.    
Aptamers are bioengineered molecules, usually based on nucleic acids, which may have 
similar binding affinity to the more conventional antibody. These biorecognition elements 
may be more stable than antibodies, and have great potential for assay design through the 
ability to place chemical agents at highly specific binding sites (Cho et al., 2009). Work is 
progressing rapidly in this area, in part through the support of NASA (Yang, 2008), but 
these reagents are much less broadly available than antibodies.    
Magnetic beads are functionalized by immobilizing antibodies or other biorecognition 
elements on the bead surface.  When exposed to the target, there is a strong affinity for 
binding.  This technique can be used to separate components from the bulk fluid efficiently.  
These processes can be exquisitely sensitive and are well-suited to sorting rare cell types; 
and they are discussed comprehensively elsewhere (Furdui & Harrison, 2004; Pamme, 2006).  
With beads as a reagent carrier, the microfluidic system becomes much more adaptable and 
resource-conscious. The same microfluidic channels can be re-used, and the set of micron-
scale beads introduced at runtime determine which assays are performed. The ability to 
discriminate among assay signals at the detection stage then becomes the chief bottleneck. 
At this time, 8-color fluorescence systems have become available commercially, which 
expands capacity greatly if appropriately fluorescing compounds can be matched to targets. 
Recent work moves towards expanding the number of fluorescing sensing stations on each 
magnetic bead, which can also increase capacity (Chan, 2009; Hu et al., 2011). Unfortunately, 
much of the current work is geared to genomics and proteomics. 
Nanostrips are ingenious new reagents that are conceptually similar to the standard 
urinalysis test strip, but the strip is shrunk a billion-fold down to the micron scale (Chan, 
2010).  As with urinalysis test strips, each nanostrip can have multiple sensor locations, each 
of which responds to a different target. The embedded reagents may be antibodies or 
aptamers tagged to fluorescent molecules that are designed for protein detection, or 
fluorescent dyes that react with other targets in the sample, such as electrolytes. These small, 
rectangular nanostrips are similar in size to blood cells, simplifying detection and analysis 
protocols. A dual-channel laser system measures the fluorescence signatures of both 
nanostrips and blood cells. For the nanostrips, one channel is dedicated to identifying the 
strip, so that the system can determine which set of targets is being measured. Essentially, 
the concentration of dye on each sensor pad creates a bar code for identifying the strip type. 
The other channel is used for the actual measurement.  Quantitative measurements are 
obtained through analysis of fluorescence intensity at each sensor location. Since the 
identification channel can easily discriminate many levels of fluorescence intensity to add 
further differentiation, a set of 5-part nanostrips could theoretically measure thousands of 
targets from a single sample. At present, nanostrips of up to 7 parts have been fabricated. As 
with the other systems discussed, a major bottleneck is assay development. Some effort in 
nanostrip delivery and data analysis techniques will also be needed. But the beauty of this 
approach is that another limiting factor may become the user’s ability to take advantage of 
nanostrip capacity.  
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4.3 Flushing and cleaning protocols 
The first step in developing flushing protocols is to define what constitutes an adequately 
clean device. Sterility is a very high standard, especially in an environment like the Space 
Station without access to an autoclave or common sterilizers, such as bleach or glutar-
aldehyde. But sterilization between each blood sample is probably unnecessary. High-
throughput systems for blood analysis, such as the Shenzhen Mindray Bio-Medical 
Electronics Co. BC-2800, can run continuously for several days before its tubing and other 
components must undergo even a routine cleaning with an enzymatic detergent. However, 
there are few commercial examples of a reusable portable device for guidance in developing 
cleaning protocols. The simplest strategy for cleaning a microdevice is to flush the system 
with saline. To assess effectiveness, quantitative measures can be used for comparison, such 
as fluorescence or color, against pre-test levels (Balagadde et al., 2005) or to some specified 
reduction, such as 10-6 times the reference signal (Verjat et al., 1999).  
For a reusable multipurpose analyzer, we must also think in terms of the assays we require 
the device to handle, the sample components that could be fouling agents, and estimated 
concentration levels for the sample. The presence of some nonspecifically adsorbed protein 
X on the wall may not matter much if we are counting cells. We are neither measuring 
protein X, nor is the attachment or detachment of protein X from the wall likely to interfere 
significantly with the cell counting. It could compromise the measurement entirely if the 
target of interest is protein X or if the target is a rare protein Y, which adsorbs to the wall, or 
displaces protein X, or protein X desorbs independently and has the unfortunate ability to 
add noise to the measurement of protein Y.  In other words, the standards for cleaning the 
device must be more exacting for measurement of a rare protein than for, say, albumin, 
which is the most common protein in blood. 
Recently, the subject of reusability in biomicrofluidics has received more attention in the 
literature. Microfluidic devices have begun to report reusability, with applications from the 
culturing of human lung carcinoma cells with a few re-uses (Jedrych et al., 2010) to the 
detection of pathogens in livestock with up to 75 assays (Kwon et al., 2010). Self-assembled 
monolayers can be deposited on the channel wall as capture agents for proteins. Although 
the binding of proteins to these monolayers is reversible, the degradation of performance 
with multiple binding/unbinding events has been substantial.  Recent efforts in this area 
have reported that the use of densely packed, short-chain monolayers in conjunction with 
controlled surface roughness can increase device lifetime to 50 uses (Choi & Chae, 2009). 
Another fascinating development has been in the area of Surface Acoustic Wave devices, in 
which an acoustic wave propagates along a solid/liquid interface for detection of binding 
events. In a device that was designed to produce a wave with a substantial surface-normal 
component, the force resulting from the surface oscillation was sufficient to remove non-
specifically bound proteins from the surface.  Also, the steady streaming motion in the fluid 
driven by the oscillating boundary prevented reattachment (Sankaranarayanan et al., 2010). 
Another recent work describes the use of nanomechanical resonant sensors in reusable 
microfluidic channels for the simultaneous detection of interleukin-8 and vascular 
endothelial growth factor in serum (Waggoner et al., 2010). Continuing efforts in promoting 
reusability are yielding insights, but much work remains to be done in this area. 
Finally, the cleanliness requirements may also vary depending on the end user. Diagnostic 
data used to treat an individual for a medical condition may require higher standards than 
biological or biomedical research. All of these areas are ripe for further exploration.  
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5. Conclusions 
In this work, we have explored the principles that can guide the design of a reusable 
biomedical device for space. The requirements that drive development for space demand far 
more attention to resource-conscious operation than a similar system designed for earth. 
However, the efficiencies provided by these considerations can also be of benefit to 
terrestrial devices by driving down costs and opening up new applications through  
reduced resource consumption, improved ruggedness, breadth of capability and enhanced 
adaptability. Some of the essential features for reusability are: 
 Continuous flow through the device to minimize sample residence time  
 Simple geometries without sharp bends, steps or expansions that could create 
separation zones or act as bubble traps  
 Minimization of sample contact with the wall through low-fouling surfaces and 
coatings, sample encapsulation, and dilution to reduce sample concentration.  
Operation in the extreme environment of space leads to additional design considerations: 
 Dry chemistry offers substantial advantages to meet the extended reagent shelf life 
needed for Exploration class missions 
 Bubble control and solids behavior may be different in a reduced gravity environment 
relative to earth and must be assessed for any spacebound device 
 The load on mission resources can be reduced by minimizing the mass, volume, power, 
and consumables of the system through hardware miniaturization, using shared 
resources, dynamic reconfiguration capabilities, and the flexibility to accommodate a 
range of assays on an array of sample types. 
Reusable devices are coming closer to maturity for some areas of biological and biomedical 
research, but there are few examples that are targeted towards a fully integrated blood and 
urine analyzer for routine medical diagnostics, as well as for a wide range of biomedical 
research needs. Nevertheless, the basic technology for such a device exists right now.  The 
primary stumbling blocks are integration of sample processing and onboard detection in a 
single device, the capacity for massive multiplexing and the availability of a broad assay 
suite. Optifluorescent detection methods are well-suited to reusable design and can 
accommodate a wide range of assays. Nanostrips can provide massive multiplexing while 
maintaining a simple, reusable geometry. These approaches hold genuine promise for 
reaching the much sought-after Holy Grail for portable biodiagnostics: a self-contained, 
robust, general-purpose assay system for analysis of bodily or environmental fluids.   
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